Nicholas A. Saccomano, President and CEO at OnKure Therapeutics, Inc. (OKUR), sold 88 shares at $2.62 ($231) on 2025-09-22, disclosed to the SEC on 2025-09-24.
Open-market sale of $231 OKUR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OKUR | SELL | 2026-03-24 | $715 | — | Filing → |
| OKUR | SELL | 2025-12-23 | $258 | — | Filing → |
| OKUR | SELL | 2025-06-25 | $209 | — | Filing → |